跳至主要内容
临床试验/EUCTR2010-023979-25-DK
EUCTR2010-023979-25-DK进行中(未招募)不适用

Role of renal and systemic vascular resistance for progression of chronic kidney disease - RenVas

Department of Nephrology0 个研究点目标入组 110 人开始时间: 2010年12月15日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • CKD grade 3-4
  • Hypertension (Blood pressure > 130/80 measured 24 h ambulatory)
  • Age> 18 years
  • Fertile women: Must have safe contraception
  • Informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Claustrophobia in a degree which makes MRI impossible
  • Ultrasound verified polycystic kidney disease
  • Pregnancy or wish to be pregnant
  • Contraindications to MRI (Pacemaker, metal implants incompatible with MRI)
  • Allergy to the medicine used in the trail
  • Blood pressure blow 130/80 (24 h ambulatory) without antihypertensive drugs
  • Blood pressure over 130/80 (24h ambulatory) while treatmented with maximum dose of beta-blocker, ACEi and CCB simultaneously.

研究者

相似试验

Role of renal and systemic vascular resistance for... | 临床试验